Study to Assess the Efficacy, Safety, and Tolerability of AZD8529 in Adult Schizophrenia Patients

NCT00921804 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

296

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: AZD 8529
DRUG: Risperidone
DRUG: Placebo to match AZD8529
DRUG: Placebo to match risperidone

Sponsor

AstraZeneca